' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Search result
Next intake of Fellowships for ‘NHS underpinned by dynamic RDI’
A fresh round of Fellowship opportunities has been announced, supporting future leaders in research, development, and innovation (RDI), and helping to solve NHS challenges The Chief Scientist Office (CSO) of Scottish Government believes that creating a positive culture across the NHS — where all staff feel empowered and supported to participate in RDI — is vital. The Fellowships aim to fulfil that need, creating the capacity and capability for talented, d...
Scottish Cross-Sector Networking Hub launches in partnership with The Academy of Medical Sciences
A new Cross-Sector Networking Hub has launched in Scotland which will draw on expertise and insight from people and organisations within life sciences and beyond to help address healthcare challenges Supported by The Academy of Medical Sciences (Academy) Cross-Sector Programme, The Hub will be hosted...
New toolkit to support research carried out across borders in the UK
The Health Research Authority (HRA), in collaboration with NHS Research Scotland, Health and Social Care (HSC) Northern Ireland and Health and Care Research Wales, has launched a new toolkit to make it easier to set up research across the UK The ‘carrying out research across borders’ toolkit is designed to support r...
UK’s first-ever norovirus mRNA vaccine trial launched
The first Phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks, it has been announced today The trial, sponsored by Moderna, is evaluating the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403. There are currently no licensed norovirus vaccines in use anywhere in the world. The Phase 3 trial - called the ‘Nova 301’ trial - will take place at 39 si...
Updated GDPR Transparency Wording Template
The Health Research Authority (HRA) has developed a series of GDPR templates to help ensure research participants have all the information they need to make an informed decision about the use of their data The updated GDPR transparency wording is relevant to anyone carrying out health and social care research in any of the four nations, with sponsors encouraged to start using the new template from Tuesday 22 October 2024. Changes to the template include more detailed informati...
Cardiovascular Network partners with Glasgow University for public innovation showcase
The Cardiovascular Network of NHS Research Scotland (NRS) will be partnering on a cutting-edge innovation showcase, inviting attendance from patients, carers, and members of the public The free interactive event on Tuesday 26 November will see the Network linking up with SoftMech, an Engineering and Physical Sciences Research Council (EPSRC)-funded Centre of Mathematics for Healthcare at the University of Glasgow to showcase the latest advances in 3D heart modelling, virtua...
‘Cornerstone gathering’ for cardiovascular and lipid research set to take place in Crieff next month
Registration has opened for next month’s Scottish Heart & Arterial disease Risk Prevention (SHARP) and Scottish Lipid Forum (SLF) annual meeting Taking place at the Crieff Hydro Hotel on Thursday 21 and Friday 22 November, the gathering will spotlight the latest advancements in cardiovascular and lipid research while providi...
Health leaders urge conference attendees to ‘Mind the Gap’ at ONE BioHub in Aberdeen
The NHS Research Scotland (NRS) Reproductive Health and Childbirth Network will be asking conference attendees to ‘Mind the Gap’ this week as it aims for unified action in accelerating vital research This overarching theme will be a significant part of the NHS Grampian Research Conference, now in its 9th year, which will take...
European first for new immunotherapy lung cancer trial in Dundee
The University of Dundee and NHS Tayside is the first hospital site in Europe to open a trial of a new investigational immunotherapy for an aggressive form of lung cancer The early-stage Phase 2 clinical trial (NCT06449209), being delivered at Ninewells Hospital in Dundee, will investigate a new dual targeting antibody treatment candidate in small cell lung cancer, co-developed by BioNTech SE and Biotheus Inc. The investigational therapy targets the tumour blood supply and aim...
Principal Investigator programme opens to Scotland-based applicants for the first time
A Principal Investigator Pipeline Programme (PIPP) is being opened to applicants working in Scotland for the first time next month The National Institute for Health and Care Research (NIHR) PIPP will offer Scotland-based research delivery nurses and midwives the opportunity to develop as Principal Investigators on NIHR portfolio studies. The programme is delivered jointly by Edinburgh and Glasgow Clinical Research Facilities. The inclusive opportunity is available to all...
